IMV Inc. (NASDAQ:IMV) is reporting third quarter earnings results on Thursday 12th November 2020, before market open.
Stock Performance
Shares of IMV Inc. traded up $ 0.17 or 4.40 percent on Wednesday, reaching $ 4.03 with volume of 558.10 thousand shares. IMV Inc. has traded high as $ 4.05 and has cracked $ 3.89 on the downward trend
The closing price of $ 4.03, representing a 185.93 % increase from the 52 week low of $ 1.35 and a 43.4 % decrease over the 52 week high of $ 6.82.
The company has a market capital of $ 267.81 million and is part of the Healthcare sector and Biotechnology industry.
Conference Call
IMV Inc. will be hosting a conference call at 8:00 AM eastern time on 12th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website imv-inc.com
IMV Inc., a clinical-stage immuno-oncology company, together with its subsidiaries, develops products based on its platform and products with a primary focus on T cell activating therapies for cancer. The companys DPX drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system. The company develops DPX-Survivac, T cell activating immunotherapy that is in Phase II clinical trials for ovarian cancer and diffuse large B-cell lymphoma.
